Personalizing treatments for individual patients with multiple myeloma

Learning objective:

After participating in this webinar, viewers should be able to:

• Discuss the treatment options for triple-class exposed patients with multiple myeloma
• Evaluate the role of bispecific antibodies and CAR T-cell therapies in the management of patients with multiple myeloma 

Faculty:

• Philippe Moreau (France)
• Paula Rodríguez-Otero (Spain)